Director of CNAG
Ivo Gut qualified in Chemistry at the University of Basel in 1985 and obtained a PhD in Physical Chemistry from the same university in 1990. Then he joined the research group of Prof. Irene Kochevar at Harvard Medical School as a Research Fellow.
Between 1993 and 1996 he was a Research Fellow with Dr. Stephan Beck at the Imperial Cancer Research Fund in London. Later, at the Max-Planck-Institute for Molecular Genetics he led a group in the Department for Vertebrate Genomics of Prof. Hans Lehrach. During 11 years, before joining the CNAG, he worked at the Centre National de Génotypage of the Commissariat à l’Energie Atomique in Evry, France, first as a Head of Technology Development and later as an Associate Director under Prof. Mark Lathrop.
His research interests are high-throughput nucleic acid analysis, sequencing, SNP genotyping, genomics, genetics, nucleic acid and protein analysis methods (molecular biological techniques and chemical modification), implementation of methods, automation and analysis. He is the author of over 140 research papers, inventor of 24 patents and patent applications, founder of 4 biotech companies (Genom Analytik GmbH, Biopsytec GmbH and Epigenomics AG, Integragen SA). He is the coordinator of the 12M€ EU FP7-funded Integrated Project READNA on DNA sequencing technology development.
Ivo Gut took on the direction of CNAG in January 2010.